TL-118 and gemcitabine drug combination display therapeutic efficacy in a MYCN amplified orthotopic neuroblastoma murine model--evaluation by MRI. [electronic resource]
Producer: 20150207Description: e90224 p. digitalISSN:- 1932-6203
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cimetidine -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Deoxycytidine -- administration & dosage
- Diclofenac -- administration & dosage
- Drug Administration Schedule
- Drug Combinations
- Drug Synergism
- Gene Amplification
- Humans
- Immunohistochemistry
- Magnetic Resonance Imaging -- methods
- Male
- Mice, Inbred NOD
- Mice, SCID
- N-Myc Proto-Oncogene Protein
- Neovascularization, Pathologic -- drug therapy
- Neuroblastoma -- blood supply
- Nuclear Proteins -- genetics
- Oncogene Proteins -- genetics
- Platelet Endothelial Cell Adhesion Molecule-1 -- metabolism
- Sulfasalazine -- administration & dosage
- Treatment Outcome
- Tretinoin -- administration & dosage
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.